ICH – Page 139 – Pharma.Tips

Microbial Limits Failure after supplier change: mixing, sampling, and hold-time controls

Understanding Microbial Limits Failure Following Supplier Change: A Comprehensive Investigation Approach In the pharmaceutical manufacturing landscape, changes in suppliers can lead to a variety of quality assurance challenges, particularly concerning…

Sedimentation Rate Oos in oral suspension manufacturing: how QA should write CAPA for inspectors

Managing Sedimentation Rate OOS in Oral Suspension Production: A Comprehensive CAPA Approach for QA Teams In the complex landscape of pharmaceutical manufacturing, deviations such as out-of-specification (OOS) results can pose…

Microbial Limits Failure during filling line setup: packaging and transport risk assessment

Investigating Microbial Limits Failure During Filling Line Setup: A Step-by-Step Approach The pharmaceutical manufacturing landscape can be complex, and ensuring microbial limits compliance during filling line setup poses significant challenges.…

Sedimentation Rate Oos at accelerated stability: mixing, sampling, and hold-time controls

Addressing Sedimentation Rate OOS Issues during Accelerated Stability in Pharmaceutical Manufacturing In the realm of pharmaceutical manufacturing, Out of Specification (OOS) results for sedimentation rates during accelerated stability studies can…

Hold Time Bioburden Rise during method transfer: mixing, sampling, and hold-time controls

Identifying the Root Causes of Hold Time Bioburden Rise during Method Transfer In the complex landscape of pharmaceutical manufacturing, maintaining product quality throughout processes is critical. A recent investigation into…

Crystallization In Syrup in oral suspension manufacturing: mixing, sampling, and hold-time controls

Investigating Crystallization Issues in Syrup Production for Oral Suspensions Crystallization during the manufacturing of oral suspensions can present significant challenges, potentially leading to quality deviations and non-compliance with Good Manufacturing…

Hold Time Bioburden Rise during method transfer: water system and sanitation checks

Addressing the Rise in Hold Time Bioburden During Method Transfers in Pharmaceutical Manufacturing In the pharmaceutical industry, maintaining product quality is paramount. A recent signal of concern has emerged regarding…

Fill Volume Variability after temperature excursion: packaging and transport risk assessment

Investigating Fill Volume Variability after Temperature Excursion in Pharmaceutical Packaging In the regulated world of pharmaceutical manufacturing, even minor deviations can lead to significant implications. One such scenario is fill…

Fill Volume Variability during EU/UK market supply: water system and sanitation checks

Understanding Fill Volume Variability in EU and UK Market Supply: A Root Cause Investigation Fill volume variability is a pressing issue that can significantly impact the compliance and quality of…

Weight Variation during tech transfer: process parameter limits and validation impacts

Addressing Weight Variations during Technical Transfer: Key Insights and Investigation Strategies Weight variation during technical transfer can present significant challenges in pharmaceutical manufacturing. These variances can impact product quality, regulatory…

Dissolution Failure during CPV review: GMP investigation steps and batch disposition

Dissolution Failures in CPV Reviews: Steps for GMP Investigation and Batch Disposition In the realm of pharmaceutical manufacturing, the failure of dissolution tests during the Continuous Process Verification (CPV) review…

Oot Dissolution Trend during FDA inspection readiness: root cause analysis with CAPA evidence pack

Root Cause Analysis for Out of Trend Dissolution During FDA Inspection Preparation As pharmaceutical manufacturers, maintaining compliance and quality control is paramount. During preparation for FDA inspections, the emergence of…